Navigation Links
Anadys Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results and Highlights
Date:2/26/2009

any intends to submit an abstract to the European Association for the Study of the Liver (EASL) to present antiviral and safety data from all three dose levels at the EASL Annual Meeting in late April.
  • 14-day Healthy Volunteer Study. In order to extend the pharmacokinetic and safety profile of ANA598, Anadys has initiated a 14-day study of ANA598 in healthy volunteers, in which subjects will receive ANA598 at dose levels of 400 mg, 800 mg, 1200 mg once-daily (QD) and 600 mg twice-daily. Enrollment of the 400 mg cohort is complete, and Anadys expects to receive the data from the full study in the second quarter of 2009.
  • Safety and PK Results for ANA598 in Healthy Volunteers. Single-dose safety and pharmacokinetic results from a Phase I study of ANA598 in healthy volunteers at doses ranging from 400 to 3000 mg were reported at the 59th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in November 2008. ANA598 was well tolerated at all doses and there were no serious adverse events or withdrawals from the study. Preclinical results for ANA598 were also reported at AASLD, including data demonstrating that the in vitro virology profile of ANA598 strongly supports clinical exploration of ANA598 in combination with interferon-alpha and with direct antivirals now in development, including protease inhibitors and nucleoside polymerase inhibitors.
  • Long-Term Chronic Toxicology Studies of ANA598. In September 2008, Anadys initiated long-term, chronic toxicology studies of ANA598 comprised of a 6-month study in rats and a 9-month study in monkeys, as well as embedded 3-month arms in both species. Anadys expects to receive full results from the 3-month arms by the end of the first quarter of 2009.
  • ANA773

    ANA773 is an oral prodrug of a small molecule inducer of endogenous interferons that acts via the to
    '/>"/>

    SOURCE Anadys Pharmaceuticals, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine news :

    1. Anadys Pharmaceuticals to Present at BIO InvestorForum 2007
    2. Anadys Pharmaceuticals to Present at Bio Investor Forum
    3. Anadys Pharmaceuticals Commences Dosing ANA598 in Hepatitis C Patients in Phase Ib Study
    4. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
    5. Anadys Pharmaceuticals to Report Fourth Quarter and Year End 2008 Financial Results
    6. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
    7. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
    8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
    9. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
    10. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
    11. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/14/2014)... News) -- Getting enough sleep each night may mean you,re less ... new study suggests. The study included more than 3,700 people ... average of seven years. Those who slept less than six ... likely to have extended absences from work due to illness, the ... from work due to sickness were those who slept between seven ...
    (Date:9/14/2014)... 2014 Top10BestSEOHosting.com always offers truly ... web host suppliers carefully, the site has announced ... are the Best WordPress Hosting suppliers in the ... a top web hosting provider, and the company’s ... web hosting provider known for its flexible hosting ...
    (Date:9/14/2014)... A new DePuy Pinnacle hip lawsuit has ... behalf of a Franklin County, Ohio man who underwent hip ... metal-on-metal hip lawsuit filed against Johnson & Johnson and its ... 40 years old when the Pinnacle Hip device was surgically ... According to the hip implant lawsuit , the man underwent ...
    (Date:9/14/2014)... School requires that children read at both near ... screened only for far vision when they enter school. , ... their eyes do not track effectively or focus (team) on ... avoid reading; at worst, they will think there is ... Children who cannot see cannot read. , On November ...
    (Date:9/13/2014)... Recently, an experienced supplier of wedding ... its new collection of eggplant evening dresses . ... discounted rates, up to 58% off. According to the ... September 23. , The company’s new items are ... vintage, plus size, modest, sexy outfits and so on. ...
    Breaking Medicine News(10 mins):Health News:A Good Night's Sleep May Mean a Good Day's Work 2Health News:Top10BestSEOHosting.com: The Best Linux Web Hosting Suppliers Now Unveiled 2Health News:Wright & Schulte LLC Files Another DePuy Pinnacle Hip Lawsuit Purporteding Risky Revision Surgery Needed Due To Failure of Metal-on-Metal Hip Replacement 2Health News:Wright & Schulte LLC Files Another DePuy Pinnacle Hip Lawsuit Purporteding Risky Revision Surgery Needed Due To Failure of Metal-on-Metal Hip Replacement 3Health News:Wright & Schulte LLC Files Another DePuy Pinnacle Hip Lawsuit Purporteding Risky Revision Surgery Needed Due To Failure of Metal-on-Metal Hip Replacement 4Health News:Wright & Schulte LLC Files Another DePuy Pinnacle Hip Lawsuit Purporteding Risky Revision Surgery Needed Due To Failure of Metal-on-Metal Hip Replacement 5Health News:Cheap Eggplant Evening Dresses Now Announced By Experienced Company iFitDress.com 2
    ... , , ST. PAUL, Minn., ... WorkFit(TM) workstation, a new sit-or-stand mobile computer workstation that enables ... to a seated position whenever they wish - reducing back ... more productive computing. , , The ...
    ... , , , ... is pleased to announce that is has added a new module ... interactions with patients. "Customer service and employee motivation are two ... their employees," says Dr. Kenneth Beer. , , ...
    ... , , MEMPHIS, Tenn., ... are seeing donations decline, St. Jude Children,s Research Hospital((R)) is receiving ... of the sixth annual Create-A-Pepper to Fight Childhood Cancer ... will observe National Childhood Cancer Awareness Month by inviting guests to ...
    ... , , , , ... Health , a comprehensive health care provider in ... Wilson A sfora, MD , ... United States Food and Drug Administration (FDA) 510(k) market clearance as a lumbar ...
    ... SHANGHAI, Aug. 27 /PRNewswire-Asia/ -- Linkwell Corporation (OTC ... disinfectants in China, announced that its 90% held,subsidiary, Shanghai ... Shield of Likang -- The Establishment of One Hundred ... 2009 to September,2010. , The ...
    ... 27, 2009) In a victory for families who dug ... Institutes of Health has awarded a $3.5-million grant to the ... for human clinical trials in a bid to halt ... human trials within four years, the NIH award was eagerly ...
    Cached Medicine News:Health News:New WorkFit Ergonomic Workstations From Ergotron 'Take a Stand' for 21st Century Office Computing 2Health News:New WorkFit Ergonomic Workstations From Ergotron 'Take a Stand' for 21st Century Office Computing 3Health News:St. Jude Children's Research Hospital(R), Chili's(R) Grill & Bar Kick-off Sixth Annual Create-A-Pepper to Fight Childhood Cancer Campaign 2Health News:St. Jude Children's Research Hospital(R), Chili's(R) Grill & Bar Kick-off Sixth Annual Create-A-Pepper to Fight Childhood Cancer Campaign 3Health News:Spinal Implant Developed by Sanford Clinic Neurosurgeon Receives FDA 510(k) Market Clearance as a Lumbar Intervertebral Body Fusion Device 2Health News:Spinal Implant Developed by Sanford Clinic Neurosurgeon Receives FDA 510(k) Market Clearance as a Lumbar Intervertebral Body Fusion Device 3Health News:Linkwell Corporation Announces Launch of the 'Establishment of 100 Model Hospitals' Across China 2Health News:Linkwell Corporation Announces Launch of the 'Establishment of 100 Model Hospitals' Across China 3Health News:NIH grant advances Tay-Sachs disease gene therapy 2Health News:NIH grant advances Tay-Sachs disease gene therapy 3
    (Date:9/12/2014)...  Rock Creek Pharmaceuticals, Inc., (NASDAQ: ... chronic inflammatory disease and neurologic disorders, announced today ... U.S. Food and Drug Administration (FDA) in response ... the formulations of Anatabloc® and CigRx® submitted by the ... FDA considers anatabine citrate, a principal ingredient in ...
    (Date:9/11/2014)... , September 11, 2014 /PRNewswire/ ... Markets ( http://www.researchandmarkets.com/research/lqkmlx/radio_frequency ) has announced the ... Identification (RFID) Market in Healthcare (Tags, ... Industry Analysis, Size, Share, Growth, Trends ... their offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ...
    (Date:9/11/2014)... Intarcia Therapeutics, Inc. today announced its participation in ... Association for the Study of Diabetes (EASD), taking place ... lead product candidate, ITCA 650, (exenatide, delivered continuously through ... global Phase 3 trials and could become the first ... 2 diabetes. Intarcia,s global ITCA 650 phase 3 ...
    Breaking Medicine Technology:Rock Creek Pharmaceuticals Receives New Dietary Ingredient Notification (NDIN) Response 2Rock Creek Pharmaceuticals Receives New Dietary Ingredient Notification (NDIN) Response 3Global Radio Frequency Identification (RFID) Market in Healthcare (Tags, Readers, Middleware, Printers and Cabinets) - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2020 2Global Radio Frequency Identification (RFID) Market in Healthcare (Tags, Readers, Middleware, Printers and Cabinets) - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2020 3Intarcia Announces Two Presentations At 50th EASD Meeting: Confirms Pivotal Phase 3 Data Announcement For ITCA 650 In Type 2 Diabetes In 4Q 2Intarcia Announces Two Presentations At 50th EASD Meeting: Confirms Pivotal Phase 3 Data Announcement For ITCA 650 In Type 2 Diabetes In 4Q 3Intarcia Announces Two Presentations At 50th EASD Meeting: Confirms Pivotal Phase 3 Data Announcement For ITCA 650 In Type 2 Diabetes In 4Q 4
    ... CITY, April 14, 2011 Booth #H1/E32 -- Varian Medical ... selection of X-ray tubes and flat panel image detectors for ... (CMEF) meeting in Shenzhen, China, April 16-18, 2011.  Varian will ... radiosurgery. Varian,s exhibit will showcase: ...
    ... Richmond Ambulance Authority (RAA) and Bon Secours Virginia ... launched a new program designed to save the lives ... cards that will help first responders provide rapid and ... (Photo: http://photos.prnewswire.com/prnh/20110414/PH82953 ) ...
    Cached Medicine Technology:Varian Medical Systems to Exhibit the Latest Digital Image Detectors, X-Ray Tubes and Cancer Treatment Technologies at the CMEF Show in Shenzhen, China 2Varian Medical Systems to Exhibit the Latest Digital Image Detectors, X-Ray Tubes and Cancer Treatment Technologies at the CMEF Show in Shenzhen, China 3Richmond Launches Nation's First Rider Alert Cards for Motorcyclists 2
    Anti-PR3 EIA Auto-Immune Markers 013-PR3-48 Proteinase...
    ... 1 (IGF-1) is a polypeptide of 70 amino ... number of related insulin-like growth factors present in ... homology with proinsulin and has a number of ... growth hormone (GH) dependent to a high degree, ...
    ...
    ...
    Medicine Products: